GlassScriptPhysician profile
Joseph A Elias
NPI 1386970705
$2,888.94
in general payments reported to CMS, 2019-2025
20 companies · $1,471 in 2025
The $1,471 reported for 2025 was more than what 91% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2022: $405 · 2023: $88.49 · 2024: $818 · 2025: $1,471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,140 · Education: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,139.52 |
| Education | $237.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $949.23 | 2024-2025 | Ensite, Mitraclip, Esprit |
| Boston Scientific Corporation | $464.13 | 2024-2025 | General - Balloon Catheters, Watchman, Watchman Flx |
| Abbvie INC. | $300.63 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $207.82 | 2019-2025 | Jardiance |
| Bridgebio Pharma, INC. | $163.26 | 2025 | Attruby |
| Edwards Lifesciences Corporation | $150.95 | 2025 | Sapien 3 Ultra Resilia |
| Merz Pharmaceuticals, LLC | $140.00 | 2022 | |
| Biosense Webster, INC. | $133.18 | 2025 | Carto 3 |
| Allergan, INC. | $111.89 | 2022 | |
| Medtronic, INC. | $62.10 | 2025 | |
| Grt US Holding, INC. | $28.04 | 2022 | |
| Aquestive Therapeutics, INC. | $24.37 | 2022 | |
| Janssen Pharmaceuticals, INC | $24.17 | 2024 | Xarelto |
| Lilly USA, LLC | $23.28 | 2024 | Kisunla, Amyvid |
| Terumo Medical Corporation | $19.24 | 2025 | Metacross Otw, Glidesheath Slender, Heartrail |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $18.54 | 2024 | Farxiga |
| Ipsen Biopharmaceuticals, INC | $18.09 | 2024 | Dysport |
| Bayer Healthcare Pharmaceuticals INC. | $17.37 | 2025 | |
| Abiomed | $16.93 | 2024 | Impella |
| Mallinckrodt Hospital Products INC. | $15.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Elias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.